Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NEOTHERAPEUTICS (NEOT) (NEOTW) -- Ignore unavailable to you. Want to Upgrade?

To: Marty who wrote (466)	6/4/1998 8:24:00 PM
From: Pierre Borczuk	Read Replies (2) \| Respond to of 705

Wow, a desparate long... >The height (depth?) of ignorance though is an assertion like >Pierre's that "Whether NEOT has a promising product ... no one >really knows" Really? Does the following statements, quoted from >NeuroInvestment, mean anything to the skeptics? They mean nothing.... NEOT has a product that stimulates certain nerve growth factors. It appears to be non-toxic from doses of 10 -4000 mg. It can be taken once a day I think the above can be supported by NEOT data. What still needs to be shown is stimulation of these growth factors in the brain has any effects on Alzheimers, parkinsons, headinjury, or spinal cord injury. If you believe that NEOT has already shown this, then i can see why you are long. If you think asking caretakers how mom/pop are doing on the medicine constitutes reliable data, then I understand why you are long. I for one, have no idea if AIT-082 is promising or not. The gold standard answer to this question is a double blind, randomized controlled trial...this is not my answer, but one that the scientific community requires. That is what the FDA will require. Until I can see this data, I cannot say the drug is promising, or recommend the stock to my friends Pierre